Bill Commons

MO SB 1454

died on adjournment

SB 1454 - This act modifies current law on the use of investigational drugs and devices for individuals with terminal illnesses to include those individuals with life-threatening or severely debilitating conditions or illnesses. Currently, investigational drugs shall not include Schedule I controlled substances. This act repeals that prohibition. This act is substantially similar to provisions in SB 1682 (2026, SCS/SB 90 (2025), SB 1767 (2026), SCS/HCS/HBs 1717 & 1643 (2026), SCS/HS/HCS/HBs 3068 & 3049 (2026), and SCS/SB 768 (2024). SARAH HASKINS

Missouri · 2026 Regular Session · upper

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did MO SB 1454 pass?

No. MO SB 1454 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-12-19): Prefiled

What is MO SB 1454 about?

MO SB 1454 is a bill in the 2026 Regular Session titled “SB 1454 - This act modifies current law on the use of investigational drugs and devices for individuals with terminal illnesses to include those individuals with life-threatening or severely debilitating conditions or illnesses. Currently, investigational drugs shall not include Schedule I controlled substances. This act repeals that prohibition. This act is substantially similar to provisions in SB 1682 (2026, SCS/SB 90 (2025), SB 1767 (2026), SCS/HCS/HBs 1717 & 1643 (2026), SCS/HS/HCS/HBs 3068 & 3049 (2026), and SCS/SB 768 (2024). SARAH HASKINS”.

Who sponsors MO SB 1454?

Brown (16), Justin is the primary sponsor of MO SB 1454.

Description

SB 1454 - This act modifies current law on the use of investigational drugs and devices for individuals with terminal illnesses to include those individuals with life-threatening or severely debilitating conditions or illnesses. Currently, investigational drugs shall not include Schedule I controlled substances. This act repeals that prohibition. This act is substantially similar to provisions in SB 1682 (2026, SCS/SB 90 (2025), SB 1767 (2026), SCS/HCS/HBs 1717 & 1643 (2026), SCS/HS/HCS/HBs 3068 & 3049 (2026), and SCS/SB 768 (2024). SARAH HASKINS

Introduced
—
Latest action
2025-12-19 — Prefiled
Bill type
bill
Last updated
—

Sponsors

  • Brown (16), Justinprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-02-05

    Second Read and Referred S Families, Seniors and Health Committee

    reading-2,referral-committee

  2. 2026-01-07

    S First Read

    reading-1

  3. 2025-12-19

    Prefiled

Versions

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_api_sync, retrieved 2026-07-31T14:08:13.255192Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MO&identifier=SB 1454. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.